banner add

Ozempic Is About to Go Generic in India, China and Canada

March 19, 2026 0
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.

from NYT > Health https://ift.tt/B25vaUK
via IFTTT
Tags:

No comments

Subscribe to: Post Comments ( Atom )

FDA Classifies Egg Recall as Class I for Highest Health Risk

Nearly 20 million eggs were recalled in July over salmonella concerns. The new classification signals a “reasonable probability” of “serious...

Theme images by PLAINVIEW. Powered by Blogger.